Revenue was $3.1 million, up 262% over prior year
Gross margin was 71%, up 2,000 basis points over prior year
Insurance authorizations and orders were a record 138
Conference call begins at 4:30 p.m. Eastern time today
BOSTON, Mass. (August 9, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three and six months ended June 30, 2021. Read more.